The Latest Breaking News from HUM

The medical industry is growing due to increased health awareness and rising chronic diseases. Moreover, increasing federal investments in healthcare are expected to boost the industry. Also, medical stocks tend to be recession-resistant because of the inelastic demand for medical products and services. So, fundamentally sound and dividend-paying medical stocks…

While the Fed announced the much-anticipated 50-bps rate hike, its hawkish tone on the course of the rate hikes has crushed investors’ optimism. Moreover, given the recessionary fears, fundamentally solid stocks PepsiCo (PEP), Humana (HUM), and Kroger (KR) might be safe buy-and-hold options. Read more.

With inflation showing no signs of slowing down, the chances of another 75-bps rate hike are increasing. Investing in healthcare stocks tends to help investors hedge against economic downturns. And given the sound prospects of the healthcare sector, fundamentally sound healthcare stocks Pfizer (PFE) and Humana (HUM) could be good…

The raging inflation is expected to increase healthcare expenditure significantly. This, along with heightened health awareness in this post-pandemic era, should drive the demand for health insurance. So, investing in fundamentally strong health insurance stocks, UnitedHealth Group (UNH) and Humana Inc. (HUM), could be wise. On the other hand, Clover…

Persistent inflationary pressure and consecutive rate hikes have hit the U.S. economy’s growth prospects and raised fears of a recession. Amid this, investing in defensive stocks Coca-Cola (KO), Humana (HUM), and Casey’s General Stores (CASY) could be wise. Read on….

Someone with a lot of money to spend has taken a bearish stance on Humana (NYSE:HUM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Amid the ongoing economic turbulence, sectors like healthcare, which enjoy inelastic demand and can pass on an increase in cost to end consumers, make a good investment option. Moreover, rising chronic diseases, an aging population, and increased healthcare spending should drive the sector’s growth. So, it could be the right…

Humana earnings flew past estimates, following Centene's Q2 beat. Centene's outlook may be even brighter if there's a recession.

Given the inelastic demand for healthcare products and services, the sector should remain resilient amid uncertain economic conditions. Therefore, Humana (HUM) and HealthEquity (HQY) should stay afloat. But which of these stocks is a better choice for investors? Read more to find out….